Rheumatoid arthritis (RA) is a chronic autoimmune disease that is associated with progressive disability, systemic complications and early death. Etiology of RA is unknown. It is assumed that environmental factors initiate RA development in genetically susceptible individuals. Epstein-Barr Virus (EBV) stimulates polyclonal B cell activation and has been suggested to play a role in RA pathogenesis. Our study aimed to study the association between EBV and RA. One hundred and sixty subjects were enrolled in the study. Eighty individuals were clinically diagnosed to have RA and confirmed by anti-CCP3 test. The remaining 80 individuals were healthy controls matched for age and sex. Serum IgG and IgM antibodies against EBV viral capsid antigen (VCA) were tested by an enzyme-linked immunosorbent assay (ELISA). The crude prevalence rate of EBV-VCA IgM antibodies among patients was (21.2%) while in healthy individuals was (8.7%) with significant OR equals to 2.8 times for RA patient's. The female prevalence rate of EBV-VCA IgM antibodies was (21.8%) higher than of male (18.7%). Moreover, the crude prevalence rate of EBV-VCA IgG antibodies for RA patients was (91.3%) while in healthy individuals was (76.3%) with significant or equals to 3.2 times for RA patients'. The female prevalence rate of EBV-VCA IgG antibodies was (95.3%) higher than of male (75%). EBV-VCA IgG and IgM antibodies titers were elevated in RA patients than in healthy controls. However, the causative relationship between EBV and RA is complex and involves different mechanisms.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic autoimmune disorder which is common among females at an older age. Worldwide prevalence of RA is estimated to be about 0.5%-1%.The cause of RA remains unclear though it has been proposed by previous studies that both genetic and environmental factors play an important role in RA pathogenesis [1] [2] [3] .RA genetic susceptibility is carried by HLA-DRB1* alleles containing the QK/RRAA or RRRAA motif in their third hyper variable region. This motif is known as the shared epitope 4 . It is associated with low occurrence of T cells specific for EBV gp110, a replicative phase glycoprotein critical for the control of EBV infection 5 . One environmental trigger may be the Epstein-Barr virus (EBV). EBV is a double-stranded DNA herpes virus that is extremely common worldwide, infecting about 98% of the human population by the age of 40 years 6 . It is transmitted through saliva. It infects and replicates in epithelial cells and B cells. EBV then becomes latent within memory B cells and persists for the lifetime of the host 7 . It causes acute infectious mononucleosis. It also reported to have association with nasopharyngeal carcinoma, Hodgkin and non-Hodgkin lymphomas, gastric carcinoma, Burkitt lymphoma and other lympho-proliferative disorders in immune compromised individuals 8 . For long time, EBV has been suspected as a possible etiology of autoimmune diseases including RA due to its high prevalence in the population and its lifelong infection after primary infection 9, 10 . The association between EBV and RA was first reported by Alspaugh and Tan. They reported that sera from RA patients were reactive against a nuclear antigen in EBVtransformed lymphocytes 11 . Association between RA pathogenesis and EBV has been linked to molecular mimicry. Several EBV antigens share similarities with self-antigens; more specifically, glycine/ alanine repeats in EBNA-1 resemble synovial proteins. Antibodies against this repeat cross-react with a 62kD protein in RA, but not in normal synovium 12, 13 .EBV DNA loads are higher in mononuclear cells isolated from active RA patients compared to healthy seropositive individuals as well as EBV serology. Furthermore, antibodies directed against cyclic citrullinated peptides (ACPA) which are used as Table 2 shows the prevalence rate of EBV-VCA IgM antibodies in different sex and age groups for RA patients and healthy controls. EBV-VCA IgM antibodies among RA females, 14 (21.8%), were higher than that of RA males, 3 (18.7%), with an OR equals to 2.7 times for females than males whereas in control females, 6 (9%), and males, 1(6%). As regard to the age, the serum EBV-VCA IgM antibodies in RA patients were highest at the age group of 40-49, years in which the rate was (30%), followed by the age group of ≥50 years (25%), then the age group of 30-39 years (18.7%), and finally the age group of 20-29 years (13.6%). Among the controls corresponding numbers were 1(10%), 3(9.3%), 2(12.5%), and 1(4%), respectively. When we compared the crude prevalence rate of EBV IgM antibodies among cases and controls we found that the crude prevalence rate among RA patients was 21.2% while among controls was 8.7%. OR of EBV infection for RA cases was 2.8 times, and this association was ranged from 1.01 up to 8.1, with significant χ2 (4.9) and statistically p equals to 0.02. Table 3 demonstrates the prevalence rate of EBV-VCA IgG antibodies in different sex and age groups of RA patients and healthy controls. The EBV-VCA IgG antibodies among females, 61 (95.3%), were higher than that of males, 12 (75%), among cases with an OR equals to 5.2 times for females than males whereas, in control females, 51(79.6%), and males, 10 (62.5%). As regard to the age, the serum EBV-VCA IgG antibodies were highest at the age group of ≥50 years old, in which the rate was (100%), followed by the age group of 40-49 years (90%), then the age group of 30-39 years (87.5%), and finally the age group of 20-29 years (81.8%). Among the controls corresponding numbers were 28(87.5%), 7(70%), 12(75%), and 14(63.6%), respectively. When we compared the crude prevalence rate of EBV IgG antibodies among cases and controls we found that the crude prevalence rate among RA patients was 91.3% while among controls was 76.3%. OR of contract EBV infection for RA cases was 3.2 times, and this association was ranged from 1.2 up to 9.2, with significant χ 2 (6.6) and statistically p equals to 0.01.
DISCUSSION
RA is a systemic autoimmune disease of unknown etiology. Both genetic and environmental factors are suggested to contribute to RA pathogenesis 1, 15 . Epstein-Barr virus was proposed as an environmental triggerof RA.It causes massive polyclonal expansion of resting lymphocytes and becomes latent within memory B cells for the lifetime of the host 16 . This study aimed to investigate the association between EBV and RA via measuring EBV-VCA IgM and IgG in RA patients compared with healthy controls. Our study showed a highly significant rate and associated OR of positive EBV-VCA IgM and IgG in RA patients than in healthy controls. Several studies have shown elevation of EBV antibodies in RA patients than healthy controls 14, 17, 18 . So far, there is no decisive theory to explain how EBV is involved in RA pathogenesis. However, several representative hypotheses on the possible mechanisms of EBV's involvement in autoimmune diseases are described 19 . One mechanism by which EBV can trigger RA is molecular mimicry 20 . Studies found antibodies against EB-encoded proteins cross-react with RA-specific proteins 7, 11, 21 . This finding supports the molecular mimicry hypothesis in RA pathogenesis either by influencing T cell receptor recognition of the HLA 'shared epitope' or through production of auto antibodies against joint antigens 6 . Molecular mimicry between a major EBV epitope and several autoantigens might contribute to a breakdown of tolerance and autoimmunity in patients with RA 22 . Another possible mechanism is through auto reactive B cells theory. It hypothesizes that in patients with certain autoimmune diseases, EBV infects auto reactive B
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17 CODEN (USA): UJPRA3 cells leading to auto antibodies production 23, 24 . Third mechanism is through the mistaken-self theory. EBVinfected B cells together with closely located activated T cells have been demonstrated in the synovial lesions of RA 25, 26 . High titers of EBV antibodies are not attributed to more frequent EBV reactivation in RA patients as a result of immune suppression therapy. Studies monitored EBV viral load in RA patients under TNF blockers for one to five. EBV load was stable over time; even when TNF blockers were associated with methotrexate [27] [28] [29] . In conclusion, high titers of EBV antibodies are associated with RA. However, the causative relationship between EBV and autoimmune diseases is complex and involves different mechanisms.
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